Youth Nicotine Use: A Growing Public Health Concern

Nov.25.2022
Youth Nicotine Use: A Growing Public Health Concern
Teenagers in the US are increasingly using e-cigarettes and flavored tobacco products, leading to concerns of nicotine addiction.

According to data from the Centers for Disease Control and Prevention, approximately 1,600 young people in this country will try their first cigarette each day.


According to the 2022 National Youth Tobacco Survey, "3.7% of middle and high school students - about 1 million in total - have tried combustible tobacco products such as cigars or cigarettes," reported Ken Alltucker of USA Today. This isn't even their most popular choice. Survey data shows that e-cigarettes are by far the most popular choice for school-age children. During the study period from January 18 to May 31, "nearly 3.1 million middle and high school students tried e-cigarettes or other tobacco products." Among adolescent e-cigarette users, "85% said they use flavored e-cigarettes, with over half using disposable e-cigarettes.


The number of people using very specific tobacco products is much higher among certain groups, and this is not a coincidence," said Matthew L. Myers, President of the non-profit organization, the Campaign for Tobacco-Free Kids. "This is directly related to the advertising positioning of the tobacco industry.


It is truly concerning that 3 million children are using these products," added Erika Sward, Assistant Vice President for National Advocacy at the American Lung Association.


Seasoning products have fueled this epidemic from the beginning," said Dennis Henigan, Vice President of Law and Regulatory Affairs for the Campaign for Tobacco-Free Kids, to USA Today.


Flavored electronic cigarettes are causing a new generation of Americans to become addicted to nicotine," wrote Margaret Foti, CEO of the American Association for Cancer Research, in a recent STAT news op-ed.


In the past decade, there has been a significant increase in the number of teenagers, young adults, and individuals who have never previously used tobacco products, using flavored electronic cigarettes and other electronic nicotine delivery systems, reaching its peak among high school students in 2019," said Forte. "While the use of these products saw a decline during the COVID-19 pandemic, their popularity is once again on the rise.


According to a report by USA Today, although the US Food and Drug Administration issued a ban in 2020 prohibiting the use of flavor cartridges in e-cigarettes that deliver nicotine, the industry seems to have found a way around this regulation by selling lab-made nicotine instead of tobacco-made nicotine. Earlier this year, the FDA warned synthetic nicotine manufacturers and retailers about the illegal sale and marketing of these products.


Swod warned that, "Until we address the root causes - wholesalers, manufacturers, and distributors - we will continue in this cycle" of young people vaping.


Foti wrote: "Prohibiting flavored (electronic nicotine delivery systems) products would be a powerful strategy for reducing their appeal to young people, and reducing the appeal of these products must be an urgent public health priority.


In late October, the American Cancer Society and the American Society of Clinical Oncology released an updated joint policy statement calling for urgent action to prevent further nicotine addiction. "It includes a ban on all flavored electronic nicotine delivery system products and strengthened regulatory enforcement," she added. The research cited by Foti suggests that young people who use these products are approximately three times more likely to start smoking traditional cigarettes than their peers who do not use them.


As cancer experts, we are increasingly concerned about the growing use of electronic nicotine delivery systems, as adolescents and young people who may not have used traditional tobacco products are now using these devices and risking addiction to nicotine, which in turn could lead to long-term use of combustible tobacco," she added.


According to an article on NewsForKids.net, a platform created by teachers to inform children about news, the problems caused by e-cigarettes could last a lifetime for those who have never smoked before. In the US, cigarettes and e-cigarettes can only be sold to adults, but many companies are attempting to lure young people into trying e-cigarettes by using flavors such as candy or cotton candy, making the e-liquid look like children's juice or candy. Therefore, many young people are starting to use e-cigarettes, believing them to be safe.


It is dangerous for young people's brain development to be exposed to nicotine. The Mayo Clinic states that for some individuals, any amount of tobacco use can quickly lead to nicotine addiction. This is the reality our children are facing.


Statement:


This article is compiled from third-party information and is intended for industry-related communication and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in the translator's ability, the translated article may not fully convey the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS is fully aligned with the Chinese government's position on any domestic, Hong Kong, Macau, Taiwan or foreign-related issues and statements.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26